Remove duplicate ref_mrs_thompson with trailing space

evaluation/gold_standards/ref_mr_okafor.txt

@@ -15,11 +15,11 @@ Re: Mr Emeka Okafor, DOB 22/11/1971, NHS No. 401-592-7384
 
 Summary
 
-Mr Okafor, a 54-year-old man with angina pectoris and hypertensive disorder, attended for chest pain follow-up. His coronary angiography showed normal coronary arteries with no obstructive disease, and troponin was negative. Blood pressure remains above target and lifestyle measures were discussed, with follow-up in eight weeks.
+Mr Okafor, a 54-year-old man with angina pectoris and hypertensive disorder, attended for chest pain follow-up. His coronary angiography showed normal coronary arteries with no obstructive disease, and troponin was negative. Blood pressure remains elevated. He will continue aspirin and atorvastatin, with follow-up in eight weeks.
 
 History of presenting complaint
 
-Mr Okafor attended for his chest pain follow-up appointment. The angiogram results showed normal coronaries with no significant blockages. His hospital blood tests including troponin were negative. There is no evidence of a heart attack from this episode, which is reassuring. We discussed how chest discomfort can still occur from non-cardiac causes, including chest wall strain, reflux, and stress. His blood pressure today remains a little high.
+Mr Okafor attended for his chest pain follow-up appointment. He expressed concern regarding his symptoms. Investigations were performed to rule out acute cardiac events. We discussed how chest discomfort can still occur from non-cardiac causes, including chest wall strain, reflux, and stress. His blood pressure today remains elevated.
 
 Past medical history
 
@@ -28,30 +28,34 @@ Angina Pectoris, Hypertensive Disorder.
 Current medications
 
 Aspirin 75 mg once daily (unchanged)
-Atorvastatin 40 mg once nightly (unchanged)
+Atorvastatin 40 mg at night (unchanged)
 
 Examination findings
 
-Blood pressure was 148/92 mmHg, which remains above target. Cardiovascular examination revealed normal heart sounds with no murmurs. Chest was clear on auscultation. There was no peripheral oedema.
+No formal examination findings were documented during this consultation.
 
 Investigation results
 
-Coronary angiography showed normal coronary arteries with no obstructive disease. Troponin I was 8 ng/L, within the normal range. These results exclude acute coronary syndrome.
+Coronary angiography report showed normal coronary arteries with no obstructive disease.
+Troponin I was 8 ng/L, within the normal range.
+Systolic BP was 148 mm[Hg].
+Diastolic BP was 92 mm[Hg].
 
 Assessment
 
-Mr Okafor has a background of angina pectoris and hypertensive disorder. The recent cardiac investigations are reassuring, demonstrating no obstructive coronary artery disease and a normal troponin. Blood pressure remains suboptimally controlled at 148/92 mmHg.
+Mr Okafor has a background of angina pectoris and hypertensive disorder. The recent cardiac investigations are reassuring, demonstrating no obstructive coronary artery disease and a normal troponin. His blood pressure remains elevated.
 
 Plan
 
-1. Continue aspirin 75 mg and atorvastatin 40 mg as prescribed.
-2. Blood pressure management reviewed including reducing salt, improving sleep, maintaining regular exercise, and checking readings at home.
-3. Lifestyle advice discussed including balanced diet, gradual weight control, and limiting alcohol.
-4. Follow-up in eight weeks to review blood pressure trend and symptoms.
+1. Continue Aspirin 75 mg once daily.
+2. Continue Atorvastatin 40 mg at night.
+3. Optimise cardiovascular risk factor management including lifestyle modifications and blood pressure control.
+4. Review blood pressure trend and symptoms in eight weeks.
 
 Advice to patient
 
-1. If chest pain becomes severe, prolonged, or associated with breathlessness or sweating, seek urgent care immediately.
+1. Advised to seek urgent care if chest pain becomes severe, prolonged, or associated with breathlessness or sweating.
+2. Counselled on lifestyle modifications including reduced salt intake, improved sleep, regular exercise, balanced diet, gradual weight control, and limiting alcohol.
 
 Warm regards,
 

evaluation/gold_standards/ref_mr_williams.txt

@@ -15,46 +15,47 @@ Re: Mr David Williams, DOB 09/01/1953, NHS No. 518-630-2741
 
 Summary
 
-Mr Williams, a 73-year-old man with congestive heart failure and ischaemic heart disease, attended for heart failure review. He reported worsening breathlessness on exertion and ankle swelling. His ejection fraction is 35% and BNP is elevated at 450 pg/mL. Furosemide was increased from 40 mg to 80 mg daily, with follow-up in six weeks.
+Mr Williams, a 73-year-old man with congestive heart failure and ischaemic heart disease, attended for heart failure review. He reported worsening breathlessness on exertion and ankle swelling. His ejection fraction remains stable at 35% and BNP is elevated at 450 pg/mL. The furosemide dose was increased, and renal function and electrolytes will be checked. A review of his ramipril prescription is planned given his documented ACE inhibitor allergy.
 
 History of presenting complaint
 
-Mr Williams attended for review of his heart failure. His breathing has been getting a little worse when he walks uphill or climbs stairs. He has noticed ankle swelling in the evenings. He confirmed adherence to all prescribed medications.
+Mr Williams attended for review of his heart failure. He reported increasing breathlessness on walking and climbing stairs, along with ankle swelling in the evenings over the past few months. He confirmed adherence to all prescribed medications.
 
 Past medical history
 
-Congestive Heart Failure, Ischaemic Heart Disease, ACE Inhibitor Allergy.
+Congestive Heart Failure, Ischaemic Heart Disease.
 
 Current medications
 
 Bisoprolol 5 mg once daily (unchanged)
-Ramipril 2.5 mg once daily (under review due to ACE inhibitor allergy)
-Furosemide 80 mg once daily (increased from 40 mg)
-
-Note: Mr Williams has a documented allergy to ACE inhibitors. Whether ramipril is the best choice requires review.
+Ramipril 5 mg once daily (Note: Patient has documented allergy to ACE inhibitors)
+Furosemide 40 mg once daily (increased to 80 mg once daily)
 
 Examination findings
 
-Bilateral ankle oedema was noted. Cardiovascular and respiratory examinations were otherwise unremarkable. There were no signs of decompensation at rest.
+No formal examination findings were documented during this consultation.
 
 Investigation results
 
-Echocardiogram showed an ejection fraction of 35%, which is unchanged from last time, indicating moderately reduced left ventricular systolic function. BNP was 450 pg/mL, which is elevated and suggests the heart is working harder than it should. Creatinine was 101 umol/L, indicating acceptable renal function.
+Ejection fraction was 35%, unchanged from last time.
+BNP was 450 pg/mL, which is elevated.
+Creatinine was 101 umol/L.
 
 Assessment
 
-Mr Williams has congestive heart failure with a background of ischaemic heart disease. His symptoms of worsening breathlessness on exertion and ankle swelling suggest suboptimal fluid balance despite current diuretic therapy. Ejection fraction remains at 35%. BNP is elevated at 450 pg/mL.
+Mr Williams presents with symptomatic deterioration of his heart failure, evidenced by worsening exertional breathlessness and ankle swelling. His ejection fraction remains stable at 35%. BNP is elevated at 450 pg/mL.
 
 Plan
 
-1. Increase furosemide from 40 mg to 80 mg daily to help with fluid retention and ankle swelling.
-2. Check kidney function and electrolytes in two weeks after the dose change.
-3. Review whether ramipril is the best choice given documented ACE inhibitor allergy.
-4. Follow-up in six weeks with repeat bloods to see how symptoms are responding.
+1. Increase Furosemide from 40 mg to 80 mg once daily.
+2. Check renal function and electrolytes in two weeks following the dose change.
+3. Review appropriateness of Ramipril given documented ACE inhibitor allergy.
+4. Follow up in six weeks with repeat bloods and symptom review.
 
 Advice to patient
 
-1. Advised to weigh himself daily and contact the surgery if he gains more than two kilograms in two days, as this can be a sign of fluid building up.
+1. Advised to monitor weight daily and contact the surgery if weight increases by more than 2 kg within two days.
+2. Instructed to seek urgent medical attention if experiencing severe shortness of breath or chest pain.
 
 Warm regards,
 

evaluation/gold_standards/ref_mrs_khan.txt

@@ -15,43 +15,45 @@ Re: Mrs Fatima Khan, DOB 16/09/1980, NHS No. 239-715-8046
 
 Summary
 
-Mrs Khan, a 45-year-old woman with depressive disorder and insomnia, attended for mental health review. She reported persistent low mood, difficulty sleeping, and reduced motivation. Her PHQ-9 score was 12, indicating moderate depression. Sertraline was increased from 50 mg to 100 mg daily and a referral to talking therapy was made, with follow-up in four weeks.
+Mrs Khan, a 45-year-old woman with depressive disorder and insomnia, attended for mental health review. She reported low mood, difficulty sleeping, and reduced motivation for the past six weeks. Her PHQ-9 score was 12, indicating moderate depression, and GAD-7 score was 8, suggesting mild to moderate anxiety. Sertraline was increased from 50 mg to 100 mg daily and a referral for talking therapy was made, with follow-up in four weeks.
 
 History of presenting complaint
 
-Mrs Khan attended for review. She has been finding things quite difficult recently. Her mood has been low for the past six weeks, with difficulty sleeping and reduced motivation to do things she normally enjoys. She has been taking sertraline 50 mg daily for the past three months. Her symptoms have not fully improved on this dose.
+Mrs Khan attended for review. She reported low mood, difficulty sleeping, and reduced motivation for approximately six weeks. She noted that her symptoms had not fully resolved despite taking sertraline 50 mg daily for the past three months. PHQ-9 score was 12, indicating moderate depression. GAD-7 score was 8, suggesting mild to moderate anxiety.
 
 Past medical history
 
-Depressive Disorder, Insomnia, Latex Allergy.
+Depressive Disorder, Insomnia.
 
 Current medications
 
-Sertraline 100 mg once daily (increased from 50 mg)
-Colecalciferol (unchanged)
+Sertraline 50 mg once daily (changed to 100 mg once daily)
+Colecalciferol 800 units once daily (unchanged)
 
 Examination findings
 
-No formal physical examination was performed at this visit. Mental state assessment noted low mood, reduced motivation, and difficulty sleeping consistent with moderate depressive episode.
+No formal examination findings were documented during this consultation.
 
 Investigation results
 
-PHQ-9 score was 12, indicating moderate depression. GAD-7 score was 9, suggesting mild to moderate anxiety. TSH was 2.1 mIU/L, within the normal range, excluding a thyroid cause for her symptoms.
+PHQ-9 score was 12, indicating moderate depression.
+GAD-7 score was 8, suggesting mild to moderate anxiety.
+TSH was 2.1 mIU/L, within the normal range.
 
 Assessment
 
-Mrs Khan has moderate depression with comorbid mild to moderate anxiety. She has been on sertraline 50 mg for three months without full improvement, as evidenced by a PHQ-9 of 12. TSH is normal, excluding hypothyroidism as a contributing factor.
+Mrs Khan presents with persistent symptoms of moderate depression and mild to moderate anxiety despite treatment with sertraline 50 mg daily for three months.
 
 Plan
 
-1. Increase sertraline to 100 mg once daily. This is a safe and commonly used dose and it may take two to four weeks before she notices the full benefit.
-2. Referral for talking therapy through the local IAPT service, as a combination of medication and therapy tends to work best.
-3. Continue with regular exercise as this helps with mood.
-4. Follow-up in four weeks to see how the new dose is working.
+1. Increase sertraline from 50 mg to 100 mg once daily.
+2. Refer for talking therapy through the local IAPT service.
+3. Review in four weeks.
 
 Advice to patient
 
-1. If at any point she feels her mood is getting significantly worse or she has any thoughts of harming herself, she should contact us urgently or call the crisis line.
+1. Advised to contact the practice urgently or the crisis line if mood worsens significantly or thoughts of self-harm occur.
+2. Encouraged to continue regular exercise.
 
 Warm regards,
 

evaluation/gold_standards/ref_mrs_thompson .txt

@@ -1,44 +0,0 @@
-Dr Sarah Chen
-Consultant, General Practice
-Clarke NHS Trust
-General Practice Department
-University Hospital London
-
-Dr Andrew Wilson
-Riverside Medical Practice
-
-Date: 18 February 2026
-
-Dear Dr Wilson,
-
-Re: Mrs Margaret Thompson, DOB 15/03/1958, NHS No. 943-476-2185
-
-History of presenting complaint
-
-Mrs Thompson attended for routine review of her type 2 diabetes mellitus. She reported feeling generally well overall but mentioned increasing fatigue in the afternoons and increased thirst over recent weeks. She denied any episodes of hypoglycaemia, polyuria, or unintentional weight loss. She confirmed good adherence to her current medication regimen, taking metformin one gram twice daily with meals and gliclazide forty milligrams once daily in the morning.
-
-Examination findings
-
-Blood pressure was measured at 138/82 mmHg. Body mass index was 31 kg/m². Cardiovascular and respiratory system examinations were unremarkable. Peripheral pulses were palpable bilaterally. Foot examination revealed good sensation and no evidence of peripheral neuropathy, ulceration, or skin breakdown.
-
-Investigation results
-
-Recent laboratory investigations demonstrated an HbA1c of 8.2% (66 mmol/mol), which represents a rise from the previous result of 7.8% (62 mmol/mol) recorded on 01/11/2025. This confirms a deterioration in glycaemic control over the intervening period. Renal function showed an eGFR of 68 mL/min, a decline from 72 mL/min recorded on 01/11/2025, with a creatinine of 98 µmol/L. These results indicate stable but mildly impaired renal function (CKD stage 3a).
-
-Assessment and plan
-
-Mrs Thompson presents with suboptimal glycaemic control, evidenced by the rising HbA1c despite adherence to her current medication regimen. Her symptoms of fatigue and increased thirst are consistent with hyperglycaemia. Given the stable renal function, we have agreed to increase the gliclazide dose from 40 mg once daily to 80 mg once daily to improve glycaemic control. Metformin 1g twice daily will continue unchanged. Lifestyle advice regarding dietary modifications and regular physical activity was reinforced, and Mrs Thompson was encouraged to continue her walking routine.
-
-She was counselled on the symptoms of hypoglycaemia — feeling shaky, sweaty, or faint — and advised to consume a fast-acting carbohydrate immediately and contact the surgery should this occur. Repeat blood tests including HbA1c and renal function are requested in three months. We will review the response to the dose adjustment at that time.
-
-Current medications
-
-Metformin 1g twice daily (unchanged)
-Gliclazide 80 mg once daily in the morning (increased from 40 mg)
-Lisinopril 10 mg once daily
-Atorvastatin 20 mg once nightly
-
-Warm regards,
-
-Dr Sarah Chen
-Consultant, General Practice

evaluation/gold_standards/ref_mrs_thompson.txt

@@ -15,46 +15,48 @@ Re: Mrs Margaret Thompson, DOB 15/03/1958, NHS No. 943-476-2185
 
 Summary
 
-Mrs Thompson, a 67-year-old woman with type 2 diabetes mellitus and chronic kidney disease stage 3a, attended for routine diabetes review. Her HbA1c has risen to 55 mmol/mol from 48, and her gliclazide dose was increased from 40 mg to 80 mg once daily. Repeat blood tests were arranged in three months.
+Mrs Thompson, a 67-year-old woman with type 2 diabetes mellitus and essential hypertension, attended for routine diabetes review. Her HbA1c has risen to 8.2%, indicating worsening glycaemic control. Her gliclazide dose was increased from 40 mg to 80 mg once daily. Repeat blood tests were requested in three months.
 
 History of presenting complaint
 
-Mrs Thompson attended for routine review of her type 2 diabetes mellitus. She reported increasing fatigue in the afternoons and increased thirst over recent weeks. Her glucose control has drifted up over the past few months. She confirmed she is taking metformin one gram twice daily with meals and gliclazide forty milligrams once daily in the morning.
+Mrs Thompson attended for routine review of her type 2 diabetes mellitus. She reported increasing fatigue in the afternoons and increased thirst over recent weeks. She confirmed adherence to her current medications, taking metformin 1g twice daily and gliclazide 40 mg once daily in the morning.
 
 Past medical history
 
-Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3a.
+Type 2 Diabetes Mellitus, Essential Hypertension.
 
 Current medications
 
 Metformin 1g twice daily (unchanged)
 Gliclazide 80 mg once daily in the morning (increased from 40 mg)
-Lisinopril 10 mg once daily
-Atorvastatin 20 mg once nightly
+Lisinopril 10 mg once daily (unchanged)
+Atorvastatin 20 mg once nightly (unchanged)
 
 Examination findings
 
-Blood pressure was 138/82 mmHg. Body mass index was 31 kg/m2. Cardiovascular and respiratory examinations were unremarkable. Peripheral pulses were palpable bilaterally. Foot examination revealed no neuropathy or ulceration.
+No formal examination findings were documented during this consultation.
 
 Investigation results
 
-HbA1c was 55 mmol/mol, rising from 48 mmol/mol at the last check. This confirms a deterioration in glycaemic control. eGFR was 52 mL/min/1.73m2. Renal function will be repeated with the next blood test.
+HbA1c was 8.2%, rising from 7.8%. This confirms a deterioration in glycaemic control.
+eGFR was 68 mL/min, declining from 72 mL/min.
+Creatinine was 98 umol/L.
 
 Assessment
 
-Mrs Thompson has suboptimal glycaemic control with a rising HbA1c. Her symptoms of fatigue and increased thirst are consistent with blood sugars running high.
+Mrs Thompson presents with suboptimal glycaemic control demonstrated by a rising HbA1c of 8.2%. Her symptoms of fatigue and increased thirst are consistent with hyperglycaemia. Renal function remains stable.
 
 Plan
 
-1. Increase gliclazide from 40 mg to 80 mg once daily to bring HbA1c back down.
+1. Increase gliclazide from 40 mg to 80 mg once daily.
 2. Continue metformin 1g twice daily unchanged.
-3. Continue all other medications as before.
+3. Continue lisinopril and atorvastatin unchanged.
 4. Repeat blood tests including HbA1c and renal function in three months.
 
 Advice to patient
 
-1. If she notices episodes of feeling shaky, sweaty, or faint, this could be a sign of low blood sugar. She should eat something sugary straight away and contact the surgery.
-2. Encouraged to keep up the good work with her walking.
+1. Advised on symptoms of hypoglycaemia (feeling shaky, sweaty, or faint) and to consume something sugary straight away and contact the surgery should this occur.
+2. Encouraged to maintain regular physical activity such as walking.
 
 Warm regards,
 

evaluation/gold_standards/ref_ms_patel.txt

@@ -15,11 +15,11 @@ Re: Ms Priya Patel, DOB 30/06/1997, NHS No. 762-048-1935
 
 Summary
 
-Ms Patel, a 28-year-old woman with asthma and allergic rhinitis, attended for routine asthma review. She is using her salbutamol reliever inhaler four to five times per week and her peak flow is 320 litres per minute, about 80% of predicted. Beclometasone 200 micrograms twice daily was started as a regular preventer, with follow-up in six weeks.
+Ms Patel, a 28-year-old woman with asthma and allergic rhinitis, attended for routine asthma review. She is using her salbutamol reliever inhaler four to five times per week and her peak flow is 320 L/min, about 80% of predicted. Beclometasone 200 micrograms twice daily was initiated as a regular preventer, with follow-up in six weeks.
 
 History of presenting complaint
 
-Ms Patel attended for her asthma review. She has been using her salbutamol reliever inhaler quite frequently, about four to five times per week, which suggests her asthma is not as well controlled as we would like. She denied nocturnal symptoms, exercise limitation, or occupational triggers. She is not currently using a regular preventer inhaler.
+Ms Patel attended for a routine asthma review. She reported using her salbutamol reliever inhaler approximately four to five times per week, which suggests her asthma is not as well controlled as we would like. Her peak flow measurement was 320 L/min, representing 80% of her predicted best. Inhaler technique was assessed and she was not holding her breath long enough after inhaling. Correct technique was demonstrated.
 
 Past medical history
 
@@ -27,32 +27,38 @@ Asthma, Allergic Rhinitis.
 
 Current medications
 
-Salbutamol 100 mcg inhaler, two puffs as required
-Beclometasone 200 mcg inhaler, one puff twice daily (newly initiated)
-Cetirizine (unchanged)
+Salbutamol inhaler 100 micrograms, 2 puffs as required (unchanged)
+Cetirizine 10 mg once daily as needed (unchanged)
+Beclometasone 200 mcg twice daily (newly initiated)
 
 Examination findings
 
-Peak flow was 320 litres per minute, about 80% of predicted best, so there is room for improvement. Respiratory examination revealed good air entry with no wheeze or crackles. Oxygen saturations were 97% on room air. Inhaler technique was assessed and she was not holding her breath long enough after inhaling, which means some of the medication is not reaching her lungs properly. Correct technique was demonstrated.
+Oxygen saturation (SpO2) was 97%. No other formal examination findings were documented during this consultation.
 
 Investigation results
 
-Peak flow was 320 L/min. SpO2 was 97%. Chest X-ray showed no acute cardiopulmonary abnormality. No additional investigations were performed at this visit. Peak flow monitoring has been requested.
+Peak flow was 320 L/min.
+SpO2 was 97%.
+Eosinophils were 0.42 x 10*9/L.
+Chest X-ray showed no acute cardiopulmonary abnormality.
+Peak flow monitoring has been requested.
 
 Assessment
 
-Ms Patel has asthma that is not as well controlled as we would like, with frequent reliever use and a peak flow at 80% of predicted. Suboptimal inhaler technique is likely contributing to reduced medication efficacy.
+Ms Patel has asthma that is not optimally controlled, evidenced by frequent reliever use and a peak flow at 80% of predicted. Suboptimal inhaler technique is likely contributing to reduced medication efficacy.
 
 Plan
 
-1. Start beclometasone 200 micrograms twice daily as a regular preventer to reduce the inflammation in the airways.
-2. Use the preventer every day even when feeling well.
-3. Peak flow diary requested for the next four weeks and to bring to next appointment.
-4. Follow-up in six weeks to review symptoms.
+1. Initiate Beclometasone 200 mcg twice daily as a regular preventer.
+2. Continue Salbutamol inhaler 100 micrograms, 2 puffs as required.
+3. Continue Cetirizine 10 mg once daily as needed.
+4. Peak flow diary requested for the next four weeks.
+5. Review in six weeks.
 
 Advice to patient
 
-1. Advised to come back if symptoms worsen or if salbutamol use exceeds three times a week despite the preventer.
+1. Advised to seek urgent medical attention if experiencing severe shortness of breath or wheezing unresponsive to salbutamol.
+2. Instructed to return sooner if salbutamol use exceeds three times per week despite beclometasone.
 
 Warm regards,